Sage Journals: Discover world-class research

Abstract

Individuals are at particularly high risk for opioid overdose following release from incarceration. While providing medications for opioid use disorder (MOUD) inside carceral facilities is a promising approach to reducing this risk, it remains under-utilized in these settings. Our primary aim was to identify barriers and facilitators of implementing MOUD programs in jails. We conducted qualitative, semi-structured interviews with 14 stakeholders (e.g., jail staff, health providers) involved in the management, planning, implementation, and linkage to care post-release of the MOUD program in one North Carolina jail in 2020 and 2021. We then conducted thematic analysis using a general inductive approach. Themes included barriers to implementation and approaches to overcome these challenges. Barriers to MOUD implementation included a lack of continuity of care between community and jail settings and stigma against MOUD. However, multiple approaches can overcome such barriers: fostering collaborations bridge carceral and non-carceral settings to ensure individuals receive high quality and continuous care and providing peer support and navigation post-release. This study provides important insight into the functioning of a MOUD program within a Southern jail that is the product of community- and state-wide partnerships. To improve health and reduce recidivism, it is important for MOUD programs to be implemented in jails across the country, based in meaningful cross-sector collaborations and peer support services.

Keywords

medications for opioid use disorder jail program implementation

Get full access to this article

View all access options for this article.

References

American Medical Association. (2024). 2024 overdose epidemic report. https://end-overdose-epidemic.org/highlights/ama-reports/2024-report/

Bandara

Kennedy-Hendricks

Merritt

Barry

C. L.

Saloner

(2021). Methadone and buprenorphine treatment in United States jails and prisons: Lessons from early adopters. Addiction, 116(12), 3473–3481. https://doi.org/10.1111/add.15565

Carroll

J. J.

Dasgupta

Ostrach

El-Sabawi

Dixon

Morrissey

Saucier

(2024). Evidence-based treatment for opioid use disorder is widely unavailable and often discouraged by providers of residential substance use services in North Carolina. Journal of Substance Use and Addiction Treatment, 167, 209474. https://doi.org/10.1016/j.josat.2024.209474

Connery

H. S.

(2015). Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions. Harvard Review of Psychiatry, 23(2), 63–75. https://doi.org/0.1097/HRP.0000000000000075

Crumpler

(2022, September 27). Opioid use disorder treatment in jails making strides in North Carolina. NC Health News. https://www.northcarolinahealthnews.org/2022/09/27/opioid-use-disorder-treatment-in-jails-making-strides-in-north-carolina/

Donnelly-DeRoven

(2022, June 6). Gaps in NC addiction treatment disproportionately hit rural residents of color. NC Health News. https://www.northcarolinahealthnews.org/2022/06/06/gaps-in-nc-addiction-treatment-disproportionately-hit-rural-residents-of-color/

Farrell-MacDonald

MacSwain

M.-A.

Cheverie

Tiesmaki

Fischer

(2014). Impact of methadone maintenance treatment on women offenders’ post-release recidivism. European Addiction Research, 20(4), 192–199. https://doi.org/10.1159/000357942

Ferguson

W. J.

Johnston

Clarke

J. G.

Koutoujian

P. J.

Maurer

Gallagher

White

Nickl

Taxman

F. S.

(2019). Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails. Health & Justice, 7(1), 19. https://doi.org/10.1186/s40352-019-0100-2

Flanagan Balawajder

Ducharme

Taylor

B. G.

Lamuda

P. A.

Kolak

Friedmann

P. D.

Pollack

H. A.

Schneider

J. A

. (2025). Barriers to universal availability of medications for opioid use disorder in US jails. JAMA Network Open, 8(4), e255340. https://doi.org/10.1001/jamanetworkopen.2025.5340

10.

Gibbs

(2013). Thematic coding and categorizing. In Gibbs

(Ed.), Analyzing qualitative data (pp. 38–56). Sage. https://doi.org/10.4135/9781849208574.n4

11.

Green

T. C.

Clarke

Brinkley-Rubinstein

Marshall

B. D. L.

Alexander-Scott

Boss

Rich

J. D.

(2018). Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiatry, 75(4), 405–407. https://doi.org/10.1001/jamapsychiatry.2017.4614

12.

Grella

C. E.

Ostile

Scott

C. K.

Dennis

Carnavale

(2020). A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system. International Journal of Drug Policy, 81, 102768. https://doi.org/10.1016/j.drugpo.2020.102768

13.

Homans

Allen

Mazariegos

(2023). A review of medication assisted treatment (MAT) in United States jails and prisons. Center for Evidence-Based Corrections. https://cchcs.ca.gov/wp-content/uploads/sites/60/MAT-in-United-States-Jails-and-Prisons-Final.pdf

14.

Hsu

Jung

O. S.

Kwan

L. T.

Jegede

Martin

Malhotra

Suzuki

(2024). Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets. Journal of Substance Use and Addiction Treatment, 157, 209216. https://doi.org/10.1016/j.josat.2023.209216

15.

Johnson

K. L.

Patel

S. V.

Cance

Rodriguez Borja

Christopher

M.-C.

Counts

Desjardins

Philbrick

S. M.

Beletsky

Ray

(2025). Implementation of harm reduction strategies in criminal-legal systems: A scoping review of the literature. Health & Justice, 13(1), 62. https://doi.org/10.1186/s40352-025-00369-x

16.

Krawczyk

Bandara

Merritt

Shah

Duncan

McEntee

Schiff

Ahmad

N. J.

Whaley

Latimore

Saloner

(2022). Jail-based treatment for opioid use disorder in the era of bail reform: A qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative. Addiction Science & Clinical Practice, 17(1), 30. https://doi.org/10.1186/s13722-022-00313-6

17.

Martin

Phillips

M. A.

Saxon

Love

Cessna

Woodard

D. L.

Page

Curry

Paone

Pennington-Stallcup

Riley

(2021). Recovery support specialists inside the jail: A program description of treatment engagement for opioid use disorder. International Journal of Prisoner Health, 17(4), 497–508. https://doi.org/10.1108/IJPH-12-2020-0102

18.

Mattson

C. L.

Tanz

L. J.

Quinn

Kariisa

Patel

Davis

N. L.

(2021). Trends and geographic patterns in drug and synthetic opioid overdose deaths – United States, 2013–2019. MMWR. Morbidity and mortality weekly report.

19.

Minnesota Department of Health. (2024). Preliminary data show a decrease in overdose deaths in 2023. https://www.health.state.mn.us

20.

Mumola

C. J.

Karberg

J. C.

(2007). Drug use and dependence, state and federal prisoners, 2004. US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.

21.

National Center for Health Statistics. (2024, May 15). U.S. Overdose deaths decrease in 2023, first time since 2018. https://www.cdc.gov/nchs/pressroom/releases/20240515.html

22.

National Institute on Drug Abuse. (2025). Medications for Opioid Use Disorder. https://nida.nih.gov/research-topics/medications-opioid-use-disorder#oud-meds-wor

23.

National Sheriffs’ Association, & National Commission on Correctional Health Care. (2018). Jail-based medication assisted treatment: Promising practices, guidelines, and resources for the field. National Institute of Corrections.

24.

North Carolina Department of Health and Human Services. (2019). Using medication-assisted treatment in jails: A North Carolina focus. North Carolina Department of Health and Human Services.

25.

Ranapurwala

S. I.

Shanahan

M. E.

Alexandridis

A. A.

Proescholdbell

S. K.

Naumann

R. B.

Edwards

Marshall

S. W.

(2018). Opioid overdose mortality among former North Carolina inmates: 2000–2015. American Journal of Public Health, 108(9), 1207–1213. https://doi.org/10.2105/AJPH.2018.304514

26.

Riessman

(2008). Thematic Analysis. In Narrative methods for the human sciences (pp. 53–76). Sage.

27.

Rudd

Seth

David

Scholl

(2016). Increases in drug and opioid-involved overdose deaths – United States, 2010–2015. MMWR. Morbidity and mortality weekly report.

28.

Sawyer

Wagner

(2022). Mass incarceration: The whole pie 2022. Prison Policy Initiative.

29.

SocioCultural Research Consultants, LLC. (2018). Dedoose Version 8.0.35, web application for managing, analyzing, and presenting qualitative and mixed method research data.

30.

Stopka

T. J.

Rottapel

R. E.

Ferguson

W. J.

Pivovarova

Toro-Mejias

Del, Friedmann

P. D.

Evans

E. A.

(2022). Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. International Journal of Drug Policy, 110, 103803. https://doi.org/10.1016/j.drugpo.2022.103803

31.

Substance Abuse and Mental Health Services Administration. (n.d.). Find substance use disorder treatment. Retrieved October 29, 2025, from https://www.samhsa.gov/substance-use/treatment/find-treatment

32.

Taylor

Moore

Wright

Brooks

Glenn

(2021). Understanding trends in jail population in Durham, North Carolina, 2014 to 2019. Data Collaborative for Justice. https://datacollaborativeforjustice.org/work/jail/understanding-trends-in-jail-population-in-durham-north-carolina-2014-to-2019/

33.

The Marshall Project. (n.d.). The state of bail reform. Retrieved February 1, 2023, from https://www.themarshallproject.org/2020/10/30/the-state-of-bail-reform?gclid=CjwKCAiAuOieBhAIEiwAgjCvcjOU_DuI4g6qI1kVbuA4kTnhlYeeOXiOV-JTCwDLp6r9ah2H3o1CshoCx3AQAvD_BwE

34.

The PEW Charitable Trusts. (2018). Jails: Inadvertent health care providers. The PEW Charitable Trusts.

35.

Thomas

D. R.

(2006). A general inductive approach for analyzing qualitative evaluation data. American Journal of Evaluation, 27(2), 237–246. https://doi.org/10.1177/1098214005283748

36.

Tillson

Fallin-Bennett

Staton

(2022). Providing peer navigation services to women with a history of opioid misuse pre- and post-release from jail: A program description. Journal of Clinical and Translational Science, 6(1), e106. https://doi.org/10.1017/cts.2022.441

37.

Victor

Hedden-Clayton

Lenz

Attaway

P. R.

Ray

(2024). Naloxone vending machines in county jail. Journal of Substance Use and Addiction Treatment, 167, 209521. https://doi.org/10.1016/j.josat.2024.209521

38.

Wildeman

Wang

E. A.

(2017). Mass incarceration, public health, and widening inequality in the USA. The Lancet, 389(10077), 1464–1474. https://doi.org/10.1016/S0140-6736(17)30259-3

39.

Winkelman

T. N. A.

Chang

V. W.

Binswanger

I. A.

(2018). Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Network Open, 1(3), e180558. https://doi.org/10.1001/jamanetworkopen.2018.0558

Medication for Opioid Use Disorder in Jail Settings: Barriers and Facilitators to Implementation

Abstract

Keywords

Get full access to this article

References